Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22784116 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation
Conditions: Graft-versus-host Disease;   Hematopoietic Stem Cell Transplantation
Intervention: Drug: Maraviroc

Study has passed its completion date and status has not been verified in more than two years.